Suzuki Fumitaka
Department of Hepatology, Toranomon Hospital, Tokyo 105-8470, Japan.
Rinsho Byori. 2008 Nov;56(11):1014-8.
Hepatitis B virus (HBV) and hepatitis C virus (HCV) are the major viruses known to cause viral hepatitis. Serological markers are commonly used as diagnostic and/or prognostic indicators of acute or chronic HBV or HCV infection. The ability to detect HBV DNA in serum has been reported to have prognostic value for the outcome of chronic HBV infection. A rapid and sustained drop in HBV DNA or HCV RNA levels in patients under therapy has been shown to be a predictive factor for a favourable treatment outcome. Various techniques for detecting HBV DNA or HCV RNA have already been described; however, there are various problems with the sensitivity or detection range of those methods. New virus measuring methods have recently been reported and used. The Cobas Taq Man HCV Test is a new method to detect HBV DNA and HCV RNA with higher sensitivity and a broader range of quantitation than conventional methods. Some reports have shown that these methods improve therapy monitoring and the management of HBV or HCV infection. Moreover, hepatitis E virus (HEV) infection has been reported in Japan. The clinical features and viral markers of HEV have also been described.
乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)是已知导致病毒性肝炎的主要病毒。血清学标志物通常用作急性或慢性HBV或HCV感染的诊断和/或预后指标。据报道,检测血清中HBV DNA的能力对慢性HBV感染的预后具有价值。接受治疗的患者中,HBV DNA或HCV RNA水平迅速且持续下降已被证明是治疗结果良好的预测因素。已经描述了多种检测HBV DNA或HCV RNA的技术;然而,这些方法在灵敏度或检测范围方面存在各种问题。最近报道并使用了新的病毒检测方法。Cobas Taq Man HCV检测是一种检测HBV DNA和HCV RNA的新方法,与传统方法相比,具有更高的灵敏度和更宽的定量范围。一些报告表明,这些方法改善了HBV或HCV感染的治疗监测和管理。此外,日本已报告戊型肝炎病毒(HEV)感染。HEV的临床特征和病毒标志物也已被描述。